Further characterization of these candidate Col10a1 regulators will open up new avenues of research that aims to better understanding skeletal developmental and disease mechanisms and may hold promise for pharmaceutical purpose to develop therapeutic targets for relevant skeletal diseases. This evidence concerns the gene COL10A1 and bone disorder.